Stephanie E. Combs

Stephanie E. Combs is a renowned Professor and Chair of the Department of Radiation Oncology at the Faculty of Medicine, Technical University of Munich (TUM), Germany, and serves as the Director of the Institute of Radiation Medicine (IRM) at Helmholtz Munich. She holds leadership roles including Dean of TUM's Faculty of Medicine (since 2022) and Chair of the Senate at TUM (since 2019).

• Studied medicine at the University of Heidelberg, Germany, with international training at Eastern Virginia Medical School and the University of Texas (UTHSCSA).
• Obtained board certification in radiation oncology (2009) and completed her Habilitation at Heidelberg, Germany.

Her research spans high-precision radiation therapies (e.g., stereotactic radiosurgery, proton therapy), radiobiology, and combination therapies (radioimmunotherapy, radiochemotherapy). She focuses on optimizing treatment for brain tumors, gastrointestinal cancers, and pediatric oncology, while pioneering biomarker development and advanced imaging techniques (e.g., PSMA-PET, delta-radiomics).

Recent publications highlight her work on radiomics for sarcoma response prediction, machine learning in glioblastoma targeting, and integrating immunotherapy with radiation. She also designed the Master of Radiation Biology program (2015) to bridge clinical and preclinical disciplines.

• 2019: Basic/Translational Senior Science Award, American Society of Radiation Oncology
• 2012: Robert Janker Award for Palliative Care
• 2010: Herrmann Holthusen Award, German Society for Radiation Oncology (DEGRO)
• 2010: Behnken-Berger Prize

Prof. Combs leads interdisciplinary teams across institutions, fostering collaborations between the IRM, TUM's University Hospital 'rechts der Isar', and national/EU research networks like the German Cancer Consortium (DKTK).